Image

Food Intake and IgA Microbiota in Anorexia Nervosa

Food Intake and IgA Microbiota in Anorexia Nervosa

Not Recruiting
18-50 years
Female
Phase N/A

Powered by AI

Overview

Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Pathophysiologic hypotheses are involving the trouble of the microbiota-gut-brain axis in the field of mental diseases.

Description

Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Here we aim to characterize the IgA-coated fraction of bacteria from the intestinal microbiota, linked to the regulation of the mucosal immune system and the epithelium physiology. Abnormalities of this microbiota are reported in inflammatory bowel disease and are associated to immune trouble. As food intake plays a key role in shaping microbiota, we aim to correlate data from IgA microbiota to food intake specificity, and to anorexia nervosa phenotypes.

Eligibility

Inclusion Criteria:

  • female subject, adult, affiliated to a social security system, under the care of the eating disorder department of university hospital of st Etienne
  • presenting a diagnosis of pure restrictive anorexia nervosa.
        For acute subgroup : BMI between 11 and 17.5 kg/m2, patient with a first episode of
        restrictive anorexia nervosa or with hyperphagic episodes.
        For the chronic subgroup: BMI between 11 and 17.5 kg/m2, disease evolving for more than 5
        years.
        For Healthy volunteer: BMI between 20 and 24 kg/m², stable weight for the last 3 months, no
        eating disorder or history of eating disorder
        Exclusion Criteria:
          -  patient does not understand French.
          -  laxative treatment in progress or stopped for less than 15 days,
          -  antibiotic treatment in the two months preceding inclusion,
          -  pre-pro or symbiotic treatment in progress or in the month preceding inclusion,
          -  patient with one of the following comorbid disorders: celiac disease, chronic
             inflammatory bowel disease, lactose intolerance, unstabilized hyperthyroidism,
             unstabilized diabetes,
          -  subject under legal protective measures.

Study details
    Anorexia Nervosa
    Healthy Volunteer

NCT05842343

Centre Hospitalier Universitaire de Saint Etienne

5 December 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.